Journal article
Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
- Abstract:
- BACKGROUND: The minimal important difference (MID) is essential for interpreting the results of randomised controlled trials (RCTs). Despite a number of RCTs in patients with malignant pleural effusions (MPEs) which use the visual analogue scale for dyspnea (VASD) as an outcome measure, the MID has not been established. METHODS: Patients with suspected MPE undergoing a pleural procedure recorded their baseline VASD and their post-procedure VASD (24 hours after the pleural drainage), and in parallel assessed their breathlessness on a 7 point Likert scale. FINDINGS: The mean decrease in VASD in patients with a MPE reporting a 'small but just worthwhile decrease' in their dyspnea (i.e. equivalent to the MID) was 19mm (95% CI 14-24mm). The mean drainage volume required to produce a change in VASD of 19mm was 760ml. INTERPRETATION: The mean MID for the VASD in patients with a MPE undergoing a pleural procedure is 19mm (95% CI 14-24mm). Thus choosing an improvement of 19mm in the VASD would be justifiable in the design and analysis of future MPE studies.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, pdf, 303.4KB, Terms of use)
-
- Publisher copy:
- 10.1371/journal.pone.0123798
Authors
- Publisher:
- PLOS
- Journal:
- PLoS ONE More from this journal
- Volume:
- 10
- Issue:
- 4
- Article number:
- e0123798
- Publication date:
- 2015-01-01
- DOI:
- EISSN:
-
1932-6203
- Language:
-
English
- Pubs id:
-
pubs:518137
- UUID:
-
uuid:ef4ccab8-e85b-44eb-b062-70bef1d03898
- Local pid:
-
pubs:518137
- Source identifiers:
-
518137
- Deposit date:
-
2015-05-20
Terms of use
- Copyright holder:
- Mishra et al
- Copyright date:
- 2015
- Notes:
- Copyright 2015 Mishra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record